4.55
Bioage Labs Inc Aktie (BIOA) Neueste Nachrichten
BioAge Labs announces first participant dosed in Phase 1 trial of BGE-102 - TipRanks
BioAge Labs begins phase 1 trial of oral NLRP3 inhibitor for obesity - Investing.com Australia
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor - MarketScreener
25% Weight Loss: BioAge's New Oral Drug Shows Breakthrough Results Combined with GLP-1s in Pre-Clinical Study - Stock Titan
Can BioAge Labs Inc. Regain Lost Ground This Quarter2025 Bull vs Bear & Free Fast Entry Momentum Trade Alerts - newsyoung.net
What is BioAge Labs Inc. s revenue forecast3x Potential Swing Trade Ideas - newsyoung.net
BioAge Labs Reports Q2 2025 Financial Results and Progress - TipRanks
Q3 EPS Estimates for BioAge Labs Decreased by William Blair - MarketBeat
Smart tools for monitoring BioAge Labs Inc.’s price actionAI-Powered Stock Trend Movement Analysis - Newser
What makes BioAge Labs Inc. stock price move sharplyFree Growth Focused Entry Plan Suggestions - Newser
Cautious Outlook on BioAge Labs, Inc. Amid Uncertainties in Clinical Developments and Market Perception - TipRanks
BioAge Labs (BIOA) Q2 Revenue Hits $2.4M - The Motley Fool
BioAge Labs (BIOA) Q2 Revenue Hits $2.4M - Nasdaq
BioAge Labs, Inc. Advances Clinical Pipeline with BGE-102 Phase 1 Trial Set for 2H 2025 and Expands APJ Agonist Pipeline - Quiver Quantitative
BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates - The Manila Times
BioAge Labs Q2 2025: BGE-102 on track for Phase 1, expanded APJ pipeline, strengthened discovery platform. - AInvest
Full technical analysis of BioAge Labs Inc. stockFree Fundamental Growth Stock Analysis - Newser
What are the technical indicators suggesting about BioAge Labs Inc.Maximize your returns with expert insights - Jammu Links News
What catalysts could drive BioAge Labs Inc. stock higher in 2025Dynamic investment growth - Jammu Links News
What is BioAge Labs Inc. company’s growth strategyHigh-margin investment plays - Jammu Links News
How does BioAge Labs Inc. compare to its industry peersDiscover undervalued stocks before they soar - Jammu Links News
Is BioAge Labs Inc. a growth stock or a value stockSkyrocketing returns - Jammu Links News
Should I hold or sell BioAge Labs Inc. stock in 2025Rapid market gains - Jammu Links News
What are the latest earnings results for BioAge Labs Inc.Navigate the market with precision tools - Jammu Links News
BioAge Labs Requests to Dismiss Class Action Filed by Investors - TradingView
BioArctic's Leqembi Achieves Massive 23.1B Yen Quarter: China Stockpiling Drives 280% Royalty Jump - Stock Titan
BioAge (BIOA) to Analyze Over 17,000 Biobank Samples for Drug Discovery - MSN
Published on: 2025-07-29 06:11:56 - beatles.ru
Price Channel Expanding on BioAge Labs Inc.’s ChartAccurate Buy Point for Momentum Stocks Detected - beatles.ru
BioAge to Analyze Over 17,000 Biobank Samples for Drug Discovery - AInvest
How to interpret RSI for BioAge Labs Inc. stockFree Trade Ready Stock Watch for Short Term - Newser
Published on: 2025-07-29 09:16:13 - metal.it
Can BioAge Labs Inc. Bounce Back From Weekly LowWeekly Top Gainers Forecast Watchlist Released - metal.it
Will BioAge Labs Inc. Benefit From Sector TailwindsReal Time Stock Movement Analysis Indicates Breakout - metal.it
Competitive Positioning of BioAge Labs Inc.: Is It Leading or LaggingLow Risk Entry Points - metal.it
How strong is BioAge Labs Inc. company’s balance sheetInvest confidently with data-backed picks - Jammu Links News
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):